Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Kintor Pharmaceutical Announces Results from Investigator-Initiated Brazil Trial Demonstrating 92% Reduction in Mortality in Hospitalized COVID-19 Patients 2021-03-11 14:54
Impact Therapeutics Announced First-Patient-Dose of Wee1 Inhibitor IMP7068 in the U.S. 2021-03-10 21:14
Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization 2021-03-10 08:00
Alphamab Received U.S. FDA IND Clearance to Initiate A Phase II Pivotal Clinical Trial of KN046 (KN046-205,ENREACH-Thymic) in the U.S. 2021-03-09 20:00
Nippon Express (Malaysia) Obtains GDP Certification for Domestic Transport Services 2021-03-09 15:00
Yangtze River Pharmaceutical (Group) Co., Ltd. Won the 2021 EFQM Global Award 2021-03-09 11:19
Winhealth Pharma and Merz Collaborate on Hepa-Merz® to benefit patients with liver disease in China 2021-03-09 10:00
CMAB Biopharma Congratulates Partner Junshi Biosciences on NMPA Acceptance of Application for a Clinical Trial of its PD-1/TGF-β Bifunctional Fusion Protein 2021-03-08 11:41
Adlai Nortye Announces Formation of its New Scientific Advisory Board 2021-03-08 09:00
Proxalutamide Phase III Clinical Trial for the Treatment of COVID-19 Patients Approved by FDA 2021-03-05 21:00
ABclonal Biotechnology Acquires Yurogen Biosystems to Better Serve Diagnostic and Pharmaceutical Researchers Worldwide 2021-03-05 20:00
Mayne Pharma launches another generic oral contraceptive 2021-03-05 05:34
Foresee Pharmaceuticals Enters Exclusive License Agreement with Intas Pharmaceuticals for Commercialization in the United States 2021-03-04 23:00
Yuyu Pharma Publishes History for 80th Anniversary 2021-03-03 22:00
I-Mab to Report Financial Results for the Full Year 2020 and Provide Corporate Update on March 29, 2021 2021-03-03 21:00
SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange 2021-03-03 16:43
CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project 2021-03-03 11:12
CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody 2021-03-02 13:43
China Biologic Announces Shareholders' Approval of Merger Agreement 2021-03-01 21:00
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index 2021-03-01 08:00
1 113 114 115 116 117 170